British Columbia Cancer Agency Branch;The University of British Columbia University-Industry Liaison Office
发明人:
Sadar, Marianne Dorothy,Mawji, Nasrin R,Banuelos, Carmen Adriana,Andersen, Raymond John,Fernandez, Javier Garcia,Jian, Kunzhong
申请号：
AU2020233630
公开号：
AU2020233630A1
申请日:
2020.09.14
申请国别(地区):
AU
年份:
2020
代理人:
摘要：
#$%^&*AU2020233630A120201015.pdf#####Abstract Compounds having a structure of Formula 1: or a pharmaceutically acceptable salt, tautomer or stereoisomer thereof, wherein RR 2, R 3, RR, R, R1C, Rld x, n 2, and n3 are as defined herein, are provided. Uses of such compounds for modulating androgen receptor activity, imaging diagnostics in cancer and therapeutics, and methods for treatment of subjects in need thereof, including prostate cancer are also provided.
